Animal Fungal Treatment Market Analysis

  • Report ID: 3130
  • Published Date: Apr 02, 2024
  • Report Format: PDF, PPT

Animal Fungal Treatment Market Analysis

Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)

Based on the distribution channel, the hospital segment is anticipated to cross USD 1.4 billion by the end of 2037. Hospital pharmacies are necessary in the field of animal fungus treatment as they offer access to specialized medicines, expert advice, and innovative therapeutic methods for complex patients. Hospital pharmacists are the major source of inpatient treatment, as they offer immediate and extensively advanced antifungal medicinal products. Another factor contributing to the growth of this market segment is the availability of specialty medicinal products. Hospital pharmacies stock a wide range of antifungals, including injectables, IV formulations, and those that are not readily available in the field. In these pharmacies, veterinarians and pharmacists also provide professional advice on the selection of medicines, dosage, or potential interactions in difficult situations.

Route of Administration (Oral, Tropical, Parenteral)

Based on the route of administration, the oral segment is expected to surpass USD 1.28 billion by the end of 2037. Compared to injections or skin treatments, administration by mouth is usually easier and more manageable for both the animal and its owner. Furthermore, the tablet formulation of oral medicine provides flexibility in the dose and ease of administration offering convenience for the animals to consume it easily by crushing it, swallowing it, or mixing it with other food products. For example, for the treatment of ringworm in dogs and cats itraconazole, an established wide-spectrum antifungal is usually administered orally as a tablet. In addition, oral medicines are often more affordable than other forms of treatment and can be accessed to a wider range of pet owners. Different brands of itraconazole tablets are marketed by companies such as Merck Animal Health and Zoetis, which contribute significantly to the animal fungal treatment market

Our in-depth analysis of the global market includes the following segments:

     Drug Type

  • Itraconazole
  •  Terbinafine
  •  Ketoconazole
  •  Fluconazole
  • Griseofulvin

     Route of Administration

  • Oral
  • Tropical
  • Parenteral

     Distribution Channel

  • Hospital Pharmacy
  •  Retail Pharmacy
  • Online Pharmacy
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3130
  • Published Date: Apr 02, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing pet ownerships and growing government initiatives are some of the major factors anticipated to drive the growth of the animal fungal treatment market.

The market is anticipated to attain a CAGR of ~6.89% over the forecast period, i.e., 2025-2037.

The major players in the market are of Neogen Corporation, MP AGRO CO., LTD., NIHON NOHYAKU CO., LTD., SynergyLabs, Dechra Pharmaceuticals, Vetoquinol, and others.

The oral segment is anticipated to garner the largest market size by the end of 2037 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2037 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample